Kelly OzurovichWatne

Associate

Los Angeles + 1.213.243.2266

Connect:

Share

Kelly Ozurovich Watne has experience litigating cases in a broad range of complex commercial matters, with an emphasis on antitrust and unfair competition litigation. She is experienced in representing international companies in complex civil litigation through trial, in both state and federal courts.

Kelly has extensive experience in representing companies in the health care industry in various litigation matters related to the provision, contracting, and pricing of health care. She also has experience in representing companies in complex cartel investigations. Kelly has represented companies targeted by the Department of Justice (DOJ) for claims of price-fixing in the computer components and capacitors industries.

Kelly maintains an active pro bono practice, focusing on representing clients in their political asylum applications. She is also a member of Jones Day's Los Angeles diversity committee.

Experience

  • ICANN obtains favorable judgment in lawsuit brought by DotConnectAfricaJones Day successfully defended ICANN (INTERNET CORP. FOR ASSIGNED NAMES & NUMBERS) against a lawsuit filed by DotConnectAfrica Trust (DCA) after ICANN denied its application for the top-level domain name ".AFRICA" for failure to demonstrate the necessary level of government endorsements.
  • STERIS acquires Cantel Medical for $3.6 billionJones Day advised STERIS plc in its acquisition of Cantel Medical Corp, a global provider of infection prevention products and services primarily to endoscopy and dental customers, for $3.6 billion.
  • Presbyterian wins Tenth Circuit affirmation of favorable summary judgment in antitrust lawsuitJones Day successfully defended Presbyterian Healthcare Services in antitrust litigation based on allegations that Presbyterian had violated federal and state antitrust laws by monopolizing the private health insurance market and by attempting to monopolize the comprehensive oncology services market.
  • Specialty engineered woods manufacturer reaches settlement in trade secret and supply agreement disputeJones Day represented an industry leader in the manufacture of specialty engineered wood products in a lawsuit against a supplier involving allegations of misappropriation of trade secrets, breach of contract, tortious interference, and unfair competition.
  • HD Supply acquired by The Home Depot, Inc. for $8.8 billionJones Day advised HD Supply, Inc. ("HDS") in its $8.8 billion acquisition by The Home Depot, Inc. ("Home Depot").
  • STERIS acquires Key Surgical for approximately $850 millionJones Day advised STERIS plc (NYSE: STE) in the $850 million acquisition of Key Surgical, a leading global provider of sterile processing, operating room, and endoscopy products, and a portfolio company of Water Street Healthcare Partners, LLC.
  • HD Supply sold its Construction & Industrial--White Cap business segment for $4 billion to an affiliate of Clayton, Dubilier & RiceJones Day advised HD Supply Holdings, Inc. in the $4 billion sale of its Construction & Industrial--White Cap business (also known as "White Cap"), a leading distributor of specialty concrete and construction products and services in North America serving professional contractors, to an affiliate of Clayton, Dubilier & Rice.
  • Petro Source defends toxic tort cases related to sale of virgin mineral spirits to Safety-KleenJones Day is defending Petro Source Investments Inc. in 20 toxic tort cases coordinated in Los Angeles.
    • View All

    June 2020

    Antitrust Alert: DOJ Passes on Opportunity To Challenge Joint Purchasing Agreement

    Summer 2019 External Publications

    Legal Victory for Student Athletes, Practical Victory for the NCAA, ABA Section of Antitrust Law

    Before sending, please note:

    Information on www.jonesday.com is for general use and is not legal advice. The mailing of this email is not intended to create, and receipt of it does not constitute, an attorney-client relationship. Anything that you send to anyone at our Firm will not be confidential or privileged unless we have agreed to represent you. If you send this email, you confirm that you have read and understand this notice.